Literature DB >> 27595922

Contribution of Caudal Müllerian Duct Mesenchyme to Prostate Development.

Hannah Brechka1, Erin M McAuley2, Sophia M Lamperis3, Gladell P Paner4, Donald J Vander Griend1,3.   

Abstract

A fundamental understanding of prostate development and tissue homeostasis has the high potential to reveal mechanisms for prostate disease initiation and identify novel therapeutic approaches for disease prevention and treatment. Our current understanding of prostate lineage specification stems from the use of developmental model systems that rely upon the embryonic preprostatic urogenital sinus mesenchyme to induce the formation of mature prostate epithelial cells. It is unclear, however, how the urogenital sinus epithelium can derive both adult urethral glands and prostate epithelia. Furthermore, the vast disparity in disease initiation between these two glands highlights key developmental factors that predispose prostate epithelia to hyperplasia and cancer. In this study we demonstrate that the caudal Müllerian duct mesenchyme (CMDM) drives prostate epithelial differentiation and is a key determinant in cell lineage specification between urethral glands and prostate epithelia. Utilizing both human embryonic stem cells and mouse embryonic tissues, we document that the CMDM is capable of inducing the specification of androgen receptor, prostate-specific antigen, NKX3.1, and Hoxb13-positive prostate epithelial cells. These results help to explain key developmental differences between prostate and urethral gland differentiation, and implicate factors secreted by the caudal Müllerian duct as novel targets for prostate disease prevention and treatment.

Entities:  

Keywords:  HOXB13; Müllerian duct; NKX3.1; androgen receptor; prostate

Mesh:

Substances:

Year:  2016        PMID: 27595922      PMCID: PMC5105354          DOI: 10.1089/scd.2016.0088

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  32 in total

1.  Epithelial differentiation of the lower urinary tract with recognition of the minor prostatic glands.

Authors:  Ronald J Cohen; Kerryn Garrett; Jemma L Golding; Robert B Thomas; John E McNeal
Journal:  Hum Pathol       Date:  2002-09       Impact factor: 3.466

Review 2.  Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?

Authors:  Ivan V Litvinov; Angelo M De Marzo; John T Isaacs
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

Review 3.  p63 and epithelial biology.

Authors:  Christopher E Barbieri; Jennifer A Pietenpol
Journal:  Exp Cell Res       Date:  2006-01-09       Impact factor: 3.905

Review 4.  Convergence of regenerative medicine and synthetic biology to develop standardized and validated models of human diseases with clinical relevance.

Authors:  Dietmar Werner Hutmacher; Boris Michael Holzapfel; Elena Maria De-Juan-Pardo; Brooke Anne Pereira; Stuart John Ellem; Daniela Loessner; Gail Petuna Risbridger
Journal:  Curr Opin Biotechnol       Date:  2015-06-26       Impact factor: 9.740

5.  Formation of human prostate epithelium using tissue recombination of rodent urogenital sinus mesenchyme and human stem cells.

Authors:  Yi Cai; Steven Kregel; Donald J Vander Griend
Journal:  J Vis Exp       Date:  2013-06-22       Impact factor: 1.355

6.  Nkx3.1, a murine homolog of Ddrosophila bagpipe, regulates epithelial ductal branching and proliferation of the prostate and palatine glands.

Authors:  M Tanaka; I Komuro; H Inagaki; N A Jenkins; N G Copeland; S Izumo
Journal:  Dev Dyn       Date:  2000-10       Impact factor: 3.780

7.  Developmental origin of vaginal epithelium.

Authors:  Takeshi Kurita
Journal:  Differentiation       Date:  2010-07-17       Impact factor: 3.880

8.  Dangerous liaisons: cooperation between Pbx3, Meis1 and Hoxa9 in leukemia.

Authors:  Ross M W Thorne; Thomas A Milne
Journal:  Haematologica       Date:  2015-07       Impact factor: 9.941

9.  Current perspectives on FOXA1 regulation of androgen receptor signaling and prostate cancer.

Authors:  Yeqing Angela Yang; Jindan Yu
Journal:  Genes Dis       Date:  2015-06

10.  Molecular mechanisms of hormone-mediated Müllerian duct regression: involvement of beta-catenin.

Authors:  S Allard; P Adin; L Gouédard; N di Clemente; N Josso; M C Orgebin-Crist; J Y Picard; F Xavier
Journal:  Development       Date:  2000-08       Impact factor: 6.868

View more
  3 in total

Review 1.  Prostate organogenesis: tissue induction, hormonal regulation and cell type specification.

Authors:  Roxanne Toivanen; Michael M Shen
Journal:  Development       Date:  2017-04-15       Impact factor: 6.868

2.  Specific deletion of LKB1/Stk11 in the Müllerian duct mesenchyme drives hyperplasia of the periurethral stroma and tumorigenesis in male mice.

Authors:  Jitu W George; Amanda L Patterson; Pradeep S Tanwar; André Kajdacsy-Balla; Gail S Prins; Jose M Teixeira
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-13       Impact factor: 11.205

3.  A pan-cancer atlas of cancer hallmark-associated candidate driver lncRNAs.

Authors:  Yulan Deng; Shangyi Luo; Xinxin Zhang; Chaoxia Zou; Huating Yuan; Gaoming Liao; Liwen Xu; Chunyu Deng; Yujia Lan; Tingting Zhao; Xu Gao; Yun Xiao; Xia Li
Journal:  Mol Oncol       Date:  2018-10-02       Impact factor: 6.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.